Price (delayed)
$28.35
Market cap
$568.9M
P/E Ratio
56.7
Dividend/share
$0.24
EPS
$0.5
Enterprise value
$559.6M
Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.